Dharminder Chauhan

37.8k citations

355 papers · 28.2k indexed · 8 hit papers · h-index 92

Impact in

Hematology top 0.01%
- Multiple Myeloma Research and Treatments
Oncology top 0.05%
- Peptidase Inhibition and Analysis

Papers in

Hematology 238
- Multiple Myeloma Research and Treatments 234
Oncology 120
- Peptidase Inhibition and Analysis 58

Co-authors: Kenneth C. Anderson Teru Hideshima Paul G. Richardson Nikhil C. Munshi Klaus Podar Constantine S. Mitsiades Noopur Raje Nicholas Mitsiades
Journals: Blood (189 papers)British Journal of Haematology (21 papers)Leukemia (16 papers)Oncogene (16 papers)Cancer Research (12 papers)
Partner nations: United States Italy Japan

In The Last Decade

Dharminder Chauhan

350 papers receiving 27.6k citations

Hit Papers

8 papers align trajectories log scale

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib 2005 · 560 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 Cancer Cell
2003 Blood
2002 Proceedings of the National Academy of Sciences
2002 Blood
2002 Blood
2002 Journal of Biological Chemistry
2001 Blood
2000 Blood

Peers

Countries citing papers authored by Dharminder Chauhan

Since Specialization

Citations

This map shows the geographic impact of Dharminder Chauhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharminder Chauhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharminder Chauhan more than expected).

Fields of papers citing papers by Dharminder Chauhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharminder Chauhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharminder Chauhan. The network helps show where Dharminder Chauhan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dharminder Chauhan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dharminder Chauhan Line = papers co-authored together Dharminder Chauhan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma Blood ·Teng Fang, Yan Song, Ting Du, Arghya Ray, A. Baibordi, Min Wang, 李文辉, Teresa León Colombo, Mu Hao, Lugui Qiu, Dharminder Chauhan, Ida Ayu Agung Idawati	2024	0
2	Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma Blood Cancer Journal ·Arghya Ray, Yan Song, Ting Du, Leutz Buon, Yu‐Tzu Tai, Dharminder Chauhan, Kenneth C. Anderson	2022	11
3	Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation Blood Cancer Discovery ·Annamaria Gullà, Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi, Mariateresa Fulciniti, 崇平熊谷, Rao Prabhala, Srikanth Talluri, Kenneth Wen, Yu‐Tzu Tai, Paul G. Richardson, Dharminder Chauhan, Tomasz Sewastianik, Ruben D. Carrasco, Nikhil C. Munshi, Kenneth C. Anderson	2021	92
4	Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells Clinical Cancer Research ·Deepika Sharma Das, Abhishek Das, Arghya Ray, Yan Song, Mehmet Samur, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson	2017	78
5	Identification of Metabolic Enzymes ENO1 and KMO As Novel Immunotherapeutic Targets in Myeloma Blood ·Arghya Ray, Deepika Sharma Das, Yan Song, Dharminder Chauhan, Kenneth C. Anderson	2017	1
6	Novel Targeted Agents in the Treatment of Multiple Myeloma Hematology/Oncology Clinics of North America ·Cindy Varga, Jacob P. Laubach, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson, Paul G. Richardson	2014	16
7	In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells Clinical Cancer Research ·Dharminder Chauhan, Arghya Ray, Kristina Viktorsson, Jack Spira, Claudia E. Paba‐Prada, Nikhil Munshi, Paul Richardson, Rolf Lewensohn, Kenneth C. Anderson	2013	79
8	Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib Clinical Cancer Research ·Melissa Ooi, Patrick Hayden, Vassiliki Kotoula, Douglas W. McMillin, Elpida Charalambous, Marcus Bergmair, Noopur Raje, Nikhil C. Munshi, Dharminder Chauhan, Teru Hideshima, Leutz Buon, Martin Clynes, Peter O’Gorman, Paul G. Richardson, Constantine S. Mitsiades, Kenneth C. Anderson, Nicholas Mitsiades	2009	53
9	Targeting Angiogenesis via a c-Myc/Hypoxia-Inducible Factor-1α–Dependent Pathway in Multiple Myeloma Cancer Research ·Jing Zhang, Martin Sattler, Giovanni Tonon, Clemens Grabher, Samir Lababidi, Bianca Feliciano de Melo, Marc S. Raab, Sonia Vallet, Yiming Zhou, María Gabriela Latorre-Rapela, Teru Hideshima, Yu‐Tzu Tai, Dharminder Chauhan, Kenneth C. Anderson, Klaus Podar	2009	76
10	Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma Leukemia ·Iris Breitkreutz, Marc S. Raab, Sonia Vallet, Teru Hideshima, Noopur Raje, Constantine S. Mitsiades, Dharminder Chauhan, Yutaka Okawa, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson	2008	166
11	Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma Cancer Research ·Klaus Podar, Marc S. Raab, Giovanni Tonon, Martin Sattler, Daniela Barilá, Jing Zhang, Yu‐Tzu Tai, Hiroshi Yasui, Noopur Raje, Ronald A. DePinho, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson	2007	55
12	The therapeutic role of targeting protein kinase C in solid and hematologic malignancies Expert Opinion on Investigational Drugs ·Klaus Podar, Marc S. Raab, Dharminder Chauhan, Kenneth C. Anderson	2007	46
13	Pharmacodynamic profiling defines the significant biological activities of the novel proteasome inhibitor NPI-0052: Comparison with Velcade® (Bortezomib) Cancer Research ·Ta‐Hsiang Chao, Dharminder Chauhan, Gordafaried Deyanat‐Yazdi, Laurence Catley, Paul G. Richardson, G. Kenneth Lloyd, Saskia Neuteboom, Kenneth C. Anderson, Michael A. Palladino	2006	1
14	Molecular characterization of PS-341 (bortezomib) resistance: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-β inhibitors Oncogene ·Teru Hideshima, Dharminder Chauhan, Kenji Ishitsuka, Hiroshi Yasui, Noopur Raje, Shaji Kumar, Klaus Podar, Constantine S. Mitsiades, Hiromasa Hideshima, Lynn Bonham, Nikhil C. Munshi, Paul G. Richardson, Jack W. Singer, Kenneth C. Anderson	2005	41
15	Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40–Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications Cancer Research ·Yu‐Tzu Tai, Xianfeng Li, Laurence Catley, Rory Coffey, Iris Breitkreutz, Jooeun Bae, Weihua Song, Klaus Podar, Teru Hideshima, Dharminder Chauhan, Robert Schlossman, Paul G. Richardson, Steven P. Treon, Iqbal S. Grewal, Nikhil C. Munshi, Kenneth C. Anderson	2005	132
16	Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application British Journal of Haematology ·Toshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, Klaus Podar, Hiroshi Yasui, Noopur Raje, Shaji Kumar, Dharminder Chauhan, Steven P. Treon, Paul G. Richardson, Kenneth C. Anderson	2004	267
17	Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma. PubMed ·Teru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, Klaus Podar, Masaharu Akiyama, Constantine Mitsiades, Nicholas Mitsiades, Baoqing Gong, Lynn Bonham, Peter de Vries, Nikhil C. Munshi, Paul G. Richardson, Jack W. Singer, Kenneth C. Anderson	2003	58
18	LAQ824 is a novel histone deacetylase inhibitor with significant activity against multiple myeloma: Results of a pre-clinical evaluation in vitro and in vivo. Blood ·LaMarr LeMee, Ellen Weisberg, YT Tai, Boris K. Lin, Nicholas Mitsiades, Teru Hideshima, Richard LeBlanc, KEIZO KANBARA, Renate Burger, C Mitsiades, Dharminder Chauhan, R Schlossman, Nikhil C. Munshi, Paul G. Richardson, Julian L. Griffin, Lvette Catarina Jabour Kairalla	2002	5
19	Apoptosis in multiple myeloma: Therapeutic implications APOPTOSIS ·Dharminder Chauhan, Kenneth C. Anderson	2001	22
20	Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells. PubMed ·Atsushi Ogata, Dharminder Chauhan, Mitsuyoshi Urashima, Gerrard Teoh, S P Treon, Kristina Anderson	1997	50

About Dharminder Chauhan

Dharminder Chauhan is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Allergy and Immunology, having authored 355 papers that have together received 28.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (234 papers), Ubiquitin and proteasome pathways (93 papers), Protein Degradation and Inhibitors (76 papers), Peptidase Inhibition and Analysis (58 papers), Immunotherapy and Immune Responses (36 papers), Cancer Mechanisms and Therapy (32 papers), Cell death mechanisms and regulation (26 papers) and Histone Deacetylase Inhibitors Research (24 papers). The work is most often cited by research in Hematology (14.9k citations), Oncology (11.1k citations), Molecular Biology (19.9k citations), Immunology (3.8k citations) and Genetics (1.9k citations). Dharminder Chauhan has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Kenneth C. Anderson, Teru Hideshima, Paul G. Richardson, Nikhil C. Munshi, Klaus Podar, Constantine S. Mitsiades, Noopur Raje, Nicholas Mitsiades, Robert Schlossman and Yu‐Tzu Tai. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Oncogene and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact